{"id":3107,"date":"2017-04-19T14:23:47","date_gmt":"2017-04-19T12:23:47","guid":{"rendered":"https:\/\/mediagnost.de\/?page_id=3107"},"modified":"2017-05-04T10:31:35","modified_gmt":"2017-05-04T08:31:35","slug":"igfbp-6-human-2","status":"publish","type":"page","link":"https:\/\/mediagnost.de\/en\/igfbp-6-human-2\/","title":{"rendered":"IGFBP-6 human"},"content":{"rendered":"

IGFBP-6<\/a> (insulin-like growth factor binding protein 6) consists of 216 amino acids, but different isoforms occur, of which the one consisting of 212 amino acids is the most common. Furthermore, IGFBP-6 can be glycosylated and phophorylated. Therefore, polyclonal antibodies are used here to allow measurement of total IGFBP-6. In addition to regulating IGF bioavailability, IGFBP-6 can inhibit cell proliferation, induce apoptosis, affect angiogenesis as well as cell migration in an IGF-independent manner.
\n<\/span><\/p>\n

The IGFBP-6 ELISA reliably determines the concentration of human IGFBP-6 in serum, plasma and cell culture supernatants.<\/span><\/p>\n

 <\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
IGFBP-6 ELISA<\/span><\/td>\n<\/tr>\n
Product number<\/td>\n\n

E112<\/p>\n<\/td>\n<\/tr>\n

Regulatory status<\/td>\n\n

RUO<\/p>\n<\/td>\n<\/tr>\n

Reference material<\/td>\neukaryotic recombinant IGFBP-6<\/td>\n<\/tr>\n
Incubation period<\/td>\n3h<\/td>\n<\/tr>\n
Antibody<\/td>\nRabbit<\/td>\n<\/tr>\n
Standard<\/td>\nrecombinant human IGFBP-6<\/td>\n<\/tr>\n
Assay Range
\n[\u00b5g\/L]<\/td>\n		0,026 – 500<\/td>\n<\/tr>\n
Samples<\/td>\n\n

Serum
\nEDTA \/ Heparin Plasma<\/p>\n<\/td>\n<\/tr>\n

Sample dilution<\/td>\n1:51<\/td>\n<\/tr>\n
analyt. Sensitivity
\n[\u00b5g\/L]<\/td>\n		0,026<\/td>\n<\/tr>\n
Intra-\/Interassay Variance [%]<\/td>\n< 10<\/td>\n<\/tr>\n
Package insert<\/td>\n\"PDF<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>","protected":false},"excerpt":{"rendered":"

IGFBP-6 (insulin-like growth factor binding protein 6) consists of 216 amino acids, but different isoforms occur, of which the one consisting of 212 amino acids is the most common. Furthermore, IGFBP-6 can be glycosylated and phophorylated. Therefore, polyclonal antibodies are used here, which ... Read More<\/a><\/p>","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"acf":[],"_links":{"self":[{"href":"https:\/\/mediagnost.de\/en\/wp-json\/wp\/v2\/pages\/3107"}],"collection":[{"href":"https:\/\/mediagnost.de\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/mediagnost.de\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/mediagnost.de\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mediagnost.de\/en\/wp-json\/wp\/v2\/comments?post=3107"}],"version-history":[{"count":4,"href":"https:\/\/mediagnost.de\/en\/wp-json\/wp\/v2\/pages\/3107\/revisions"}],"predecessor-version":[{"id":3724,"href":"https:\/\/mediagnost.de\/en\/wp-json\/wp\/v2\/pages\/3107\/revisions\/3724"}],"wp:attachment":[{"href":"https:\/\/mediagnost.de\/en\/wp-json\/wp\/v2\/media?parent=3107"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}